microRNA involvement in human cancer

Carcinogenesis

Volumn 33, Issue 6, 2012, Pages 1126-1133

  Iorio, Marilena V ^a   Croce, Carlo M ^b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 10B; MICRORNA 126; MICRORNA 205; MICRORNA 21; MICRORNA 9; MIRNA 335; MIRNA 373; MIRNA 520C; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANGIOGENESIS; ARTICLE; CANCER RESISTANCE; CARCINOGENESIS; CELL MIGRATION; CELL PROLIFERATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; HUMAN; MOLECULAR INTERACTION; NEOPLASM; NONHUMAN; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; REGULATORY MECHANISM; TUMOR SUPPRESSOR GENE;

DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84864300017     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs140     Document Type: Article

References (126)

1. Ruby,J.G. et al. (2007) Intronic microRNA precursors that bypass Drosha processing. Nature, 448, 83-86.
2. Lee,Y. et al. (2004) MicroRNA genes are transcribed by RNA polymerase II.. EMBO J., 23, 4051-4060.
3. Cai,X. et al. (2004) Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA, 10, 1957-1966.
4. Lee,Y. et al. (2003) The nuclear RNase III Drosha initiates microRNA processing. Nature, 425, 415-419.
5. Yi,R. et al. (2003) Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev., 17, 3011-3016.
6. Bhayani,M. K. et al. (2012) Functional relevance of miRNA* sequences in human disease. Mutat. Res., 731, 14-19.
7. Vasudevan,S. et al. (2007) Switching from repression to activation: microRNAs can up-regulate translation. Science, 318, 1931-1934.
8. Kim, V.N. (2005) MicroRNA biogenesis: coordinated cropping and dicing. Nat. Rev. Mol. Cell Biol., 6, 376-385.
9. Berezikov,E. et al. (2007) Mammalian mirtron genes. Mol. Cell, 28, 328-336.
10. Okamura,K. et al. (2007) The mirtron pathway generates microRNAclass regulatory RNAs in Drosophila. Cell, 130, 89-100.
11. Ørom,U.A. et al. (2008) MicroRNA-10a binds the 5'UTR of ribosomal protein mRNAs and enhances their translation. Mol. Cell, 30, 460-471.
12. Lytle,J.R. et al. (2007) Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5' UTR as in the 3' UTR. Proc. Natl Acad. Sci. USA, 104, 9667-9672.
13. Moretti,F. et al. (2010) Mechanism of translational regulation by miR-2 from sites in the 5' untranslated region or the open reading frame. RNA, 16, 2493-2502.
14. Qin,W. et al. (2010) miR-24 regulates apoptosis by targeting the open reading frame (ORF) region of FAF1 in cancer cells. PLoS One, 5, e9429.
15. Hwang,H. W. et al. (2007) A hexanucleotide element directs microRNA nuclear import. Science, 315, 97-100.
16. Valadi,H. et al. (2007) Exosome-mediated transfer of mRNAs and micro-RNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol., 9, 654-659.
17. Calin,G.A. et al. (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl Acad. Sci. USA, 101, 2999-3004.
18. Calin,G.A. et al. (2006) MicroRNA signatures in human cancers. Nat. Rev. Cancer, 6, 857-866.
19. Liu,C.G. et al. (2004) An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc. Natl Acad. Sci. USA, 101, 9740-9744.
20. Lu,J. et al. (2005) MicroRNA expression profiles classify human cancers. Nature, 435, 834-838.
21. Creighton,C.J. et al. (2009) Expression profiling of microRNAs by deep sequencing. Brief. Bioinform., 10, 490-497.
22. Farazi,T.A. et al. (2011) MicroRNA sequence and expression analysis in breast tumors by deep sequencing. Cancer Res., 71, 4443-4453.
23. Blenkiron,C. et al. (2007) MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol., 8, R21.
24. Sempere,L.F. et al. (2007) Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer. Cancer Res., 67, 11612-11620.
25. Mattie,M.D. et al. (2006) Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol. Cancer, 5, 24.
26. Lowery,A.J. et al. (2009) MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer. Breast Cancer Res., 11, R27.
27. Iorio,M.V. et al. (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res., 65, 7065-7070.
28. Calin,G.A. et al. (2005) A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N. Engl. J. Med., 353, 1793-1801.
29. Yanaihara,N. et al. (2006) Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell, 9, 189-198.
30. Li,X. et al. (2010) Survival prediction of gastric cancer by a seven-micro-RNA signature. Gut, 59, 579-585.
31. Caramuta,S. et al. (2010) MicroRNA expression profiles associated with mutational status and survival in malignant melanoma. J. Invest. Dermatol., 130, 2062-2070.
32. Schetter,A.J. et al. (2008) MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA, 299, 425-436.
33. Giovannetti,E. et al. (2010) MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity. Cancer Res., 70, 4528-4538.
34. Calin,G.A. et al. (2002) Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl Acad. Sci. USA, 99, 15524-15529.
35. Zhang,L. et al. (2006) microRNAs exhibit high frequency genomic alterations in human cancer. Proc. Natl Acad. Sci. USA, 103, 9136-9141.
36. Tagawa,H. et al. (2005) A microRNA cluster as a target of genomic amplification in malignant lymphoma. Leukemia, 19, 2013-2016.
37. Raveche,E.S. et al. (2007) Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice. Blood, 109, 5079-5086.
38. Hu,Z. et al. (2008) Genetic variants of miRNA sequences and non-small cell lung cancer survival. J. Clin. Invest., 118, 2600-2608.
39. Weber,B. et al. (2007) Methylation of human microRNA genes in normal and neoplastic cells. Cell Cycle, 6, 1001-1005.
40. Saito,Y. et al. (2006) Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell, 9, 435-443.
41. Lehmann,U. et al. (2008) Epigenetic inactivation of microRNA gene hsamir-9-1 in human breast cancer. J. Pathol., 214, 17-24.
42. Toyota,M. et al. (2008) Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res., 68, 4123-4132.
43. Lujambio,A. et al. (2007) Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res., 67, 1424-1429.
44. Brueckner,B. et al. (2007) The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function. Cancer Res., 67, 1419-1423.
45. Iorio,M.V. et al. (2007) MicroRNA signatures in human ovarian cancer. Cancer Res., 67, 8699-8707.
46. Scott,G.K. et al. (2006) Rapid alteration of microRNA levels by histone deacetylase inhibition. Cancer Res., 66, 1277-1281.
47. Shin,S. et al. (2009) MicroRNAs that respond to histone deacetylase inhibitor SAHA and p.53 in HCT116 human colon carcinoma cells. Int. J. Oncol., 35, 1343-1352.
48. Bandres,E. et al. (2009) Epigenetic regulation of microRNA expression in colorectal cancer. Int. J. Cancer, 125, 2737-2743.
49. Saito,Y. et al. (2009) Chromatin remodeling at Alu repeats by epigenetic treatment activates silenced microRNA-512-5p with downregulation of Mcl-1 in human gastric cancer cells. Oncogene, 28, 2738-2744.
50. Rhodes,L.V. et al. (2012) The histone deacetylase inhibitor trichostatin A alters microRNA expression profiles in apoptosis-resistant breast cancer cells. Oncol. Rep., 27, 10-16doi: 10.3892/or.2011.1488.
51. Fabbri,M. et al. (2007) MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc. Natl Acad. Sci. USA, 104, 15805-15810.
52. Garzon,R. et al. (2009) MicroRNA 29b functions in acute myeloid leukemia. Blood, 114, 5331-5341.
53. Benetti,R. et al. (2008) A mammalian microRNA cluster controls DNA methylation and telomere recombination via Rbl2-dependent regulation of DNA methyltransferases. Nat. Struct. Mol. Biol., 15, 268-279.
54. Sinkkonen,L. et al. (2008) MicroRNAs control de novo DNA methylation through regulation of transcriptional repressors in mouse embryonic stem cells. Nat. Struct. Mol. Biol., 15, 259-267.
55. Chen,J.F. et al. (2006) The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet., 38, 228-233.
56. Roccaro,A.M. et al. (2010) microRNA-dependent modulation of histone acetylation in Waldenstrom macroglobulinemia. Blood, 116, 1506-1514.
57. Wang,Y. et al. (2007) DGCR8 is essential for microRNA biogenesis and silencing of embryonic stem cell self-renewal. Nat. Genet., 39, 380-385.
58. Viswanathan,S.R. et al. (2008) Selective blockade of microRNA processing by Lin28. Science, 320, 97-100.
59. Kumar,M.S. et al. (2009) Dicer1 functions as a haploinsufficient tumor suppressor. Genes Dev., 23, 2700-2704.
60. Karube,Y. et al. (2005) Reduced expression of Dicer associated with poor prognosis in lung cancer patients. Cancer Sci., 96, 111-115.
61. Merritt,W.M. et al. (2008) Dicer, Drosha, and outcomes in patients with ovarian cancer. N. Engl. J. Med., 359, 2641-2650.
62. Guo,X. et al. (2012) The microRNA-processing enzymes: Drosha and Dicer can predict prognosis of nasopharyngeal carcinoma. J. Cancer Res. Clin. Oncol., 138, 49-56.
63. Lin,R.J. et al. (2010) microRNA signature and expression of Dicer and Drosha can predict prognosis and delineate risk groups in neuroblastoma. Cancer Res., 70, 7841-7850.
64. Grelier,G. et al. (2009) Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype. Br. J. Cancer, 101, 673-683.
65. Faber,C. et al. (2011) Overexpression of Dicer predicts poor survival in colorectal cancer. Eur. J. Cancer, 47, 1414-1419.
66. Chiosea,S. et al. (2006) Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma. Am. J. Pathol., 169, 1812-1820.
67. Muralidhar,B. et al. (2011) Functional evidence that Drosha overexpression in cervical squamous cell carcinoma affects cell phenotype and microRNA profiles. J. Pathol., 224, 496-507doi: 10.1002/path. 2898.
68. Martello,G. et al. (2010) A MicroRNA targeting dicer for metastasis control. Cell, 141, 1195-1207.
69. Tang,R. et al. (2012) Mouse miRNA-709 directly regulates miRNA-15a/16-1 biogenesis at the posttranscriptional level in the nucleus: evidence for a microRNA hierarchy system. Cell Res., 22, 504-515 doi: 10.1038/cr.2011.137.
70. He,L. et al. (2007) A microRNA component of the p53 tumour suppressor network. Nature, 447, 1130-1134.
71. Chang,T.C. et al. (2007) Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol. Cell, 26, 745-752.
72. Piovan,C. et al. Oncosuppressive role of p53-induced miR-205 in triple negative breast cancer. Mol. Oncol, in press.
73. Chang,T.C. et al. (2009) Lin-28B transactivation is necessary for Mycmediated let-7 repression and proliferation. Proc. Natl Acad. Sci. USA, 106, 3384-3389.
74. Mott,J.L. et al. (2010) Transcriptional suppression of mir-29b-1/mir-29a promoter by c-Myc, hedgehog, and NF-kappaB. J. Cell. Biochem., 110, 1155-1164.
75. Burk,U. et al. (2008) A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO, 9, 582-589.
76. Gregory,P.A. et al. (2008) MicroRNAs as regulators of epithelial-mesenchymal transition. Cell Cycle, 7, 3112-3118.
77. Cimmino,A. et al. (2005) miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl Acad. Sci. USA, 102, 13944-13949.
78. Johnson,S.M. et al. (2005) RAS is regulated by the let-7 microRNA family. Cell, 120, 635-647.
79. Sampson,V.B. et al. (2007) MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res., 67, 9762-9770.
80. Ciafre,S.A. et al. (2005) Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem. Biophys. Res. Commun., 334, 1351-1358.
81. Bloomston,M. et al. (2007) MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA, 297, 1901-1908.
82. Chan,J.A. et al. (2005) MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res., 65, 6029-6033.
83. Frankel,L.B. et al. (2008) Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J. Biol. Chem., 283, 1026-1033.
84. Medina,P.P. et al. (2010) OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature, 467, 86-90.
85. Garzon,R. et al. (2008) MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood, 111, 3183-3189.
86. He,L. et al. (2005) A microRNA polycistron as a potential human oncogene. Nature, 435, 828-833.
87. Xiao,C. et al. (2008) Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat. Immunol., 9, 405-414.
88. Mu,P. et al. (2009) Genetic dissection of the miR-17~92 cluster of micro-RNAs in Myc-induced B-cell lymphomas. Genes Dev., 23, 2806-2811.
89. Costinean,S. et al. (2006) Pre-B cell proliferation and lymphoblastic leukemia/ high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc. Natl Acad. Sci. USA, 103, 7024-7029.
90. Meng,F. et al. (2006) Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology, 130, 2113-2129.
91. Kovalchuk,O. et al. (2008) Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin. Mol. Cancer Ther., 7, 2152-2159.
92. Xia,L. et al. (2008) miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int. J. Cancer, 123, 372-379.
93. Chen,F. et al. (2010) Inhibition of c-FLIP expression by miR-512-3p contributes to taxol-induced apoptosis in hepatocellular carcinoma cells. Oncol. Rep., 23, 1457-1462.
94. Zhao,J.J. et al. (2008) MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer. J. Biol. Chem., 283, 31079-31086.
95. Miller,T.E. et al. (2008) MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1. J. Biol. Chem., 283, 29897-29903.
96. Rao,X. et al. (2011) MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways. Oncogene, 30, 1082-1097.
97. Iorio,M.V. et al. (2009) microRNA-205 regulates HER3 in human breast cancer. Cancer Res., 69, 2195-2200.
98. Hurst,D.R. et al. (2009) Metastamir: the field of metastasis-regulatory microRNA is spreading. Cancer Res., 69, 7495-7749.
99. Ma,L. et al. (2007) Tumour invasion and metastasis initiated by micro-RNA-10b in breast cancer. Nature, 449, 682-688.
100. Ma,L. et al. (2010) Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model. Nat. Biotechnol., 28, 341-347.
101. Asangani,I.A. et al. (2008) MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene, 27, 2128-2136.
102. Zhu,S. et al. (2008) MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res., 18, 350-359.
103. Voorhoeve,P.M. et al. (2006) A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell, 124, 1169-1181.
104. Huang,Q. et al. (2008) The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat. Cell Biol., 10, 202-210.
105. Li,N. et al. (2009) miR-34a inhibits migration and invasion by downregulation of c-Met expression in human hepatocellular carcinoma cells. Cancer Lett., 275, 44-53.
106. Wu,H. et al. (2009) Suppression of cell growth and invasion by miR-205 in breast cancer. Cell Res., 19, 439-448.
107. Tavazoie,S.F. et al. (2008) Endogenous human microRNAs that suppress breast cancer metastasis. Nature, 451, 147-152.
108. Png,K.J. et al. (2011) A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells. Nature, 481, 190-194. doi: 10.1038/nature10661.
109. Khew-Goodall,Y. et al. (2012) Stromal miR-320 keeps an oncogenic secretome in check. Nat. Cell Biol., 14, 124-125. doi: 10.1038/ncb2431.
110. Pulkkinen,K. et al. (2008) Hypoxia induces microRNA miR-210 in vitro and in vivo ephrin-A3 and neuronal pentraxin 1 are potentially regulated by miR-210. FEBS Lett., 582, 2397-2401.
111. Dews,M. et al. (2006) Augmentation of tumor angiogenesis by a Mycactivated microRNA cluster. Nat. Genet., 38, 1060-1065.
112. Poliseno,L. et al. (2006) MicroRNAs modulate the angiogenic properties of HUVECs. Blood, 108, 3068-3071.
113. Ma,L. et al. (2010) miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat. Cell Biol., 12, 247-256.
114. Rosenfeld,N. et al. (2008) MicroRNAs accurately identify cancer tissue origin. Nat. Biotechnol., 26, 462-469.
115. Bernstein,E. et al. (2003) Dicer is essential for mouse development. Nat. Genet., 35, 215-217.
116. Calabrese,J.M. et al. (2007) RNA sequence analysis defines Dicer's role in mouse embryonic stem cells. Proc. Natl Acad. Sci. USA, 104, 18097- 18102 Erratum in: Proc. Natl Acad. Sci. USA. 2007, 104, 21021.
117. Yu,F. et al. (2007) let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell, 131, 1109-1123.
118. Shimono,Y. et al. (2009) Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell, 138, 592-603.
119. Wellner,U. et al. (2009) The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat. Cell Biol., 11, 1487-1495.
120. Hsu,P.W. et al. (2006) miRNAMap: genomic maps of microRNA genes and their target genes in mammalian genomes. Nucleic Acids Res., 34, D135-D139.
121. Chi,S.W. et al. (2009) Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature, 460, 479-486.
122. Calin,G.A. et al. (2007) Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. Cancer Cell, 12, 215-229.
123. Salmena,L. et al. (2011) A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell, 146, 353-358.
124. Chin,L.J. et al. (2008) A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk. Cancer Res., 68, 8535-8540.
125. Sandberg,R. et al. (2008) Proliferating cells express mRNAs with shortened 3' untranslated regions and fewer microRNA target sites. Science, 320, 1643-1647.
126. Iorio,M.V. et al. (2012) MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol. Med., 4, 143-159. doi: 10.1002/emmm.201100209.